Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Agency

All agencies FDA (Food)FDA (Drugs)FDA (Devices)USDA FSIS CPSC NHTSA EPA

826–840 of 840

CriticalFDA (Drugs)·D-138-2013·2013-02-06
Qualitest Recalls Hydrocodone and Acetaminophen Tablets Due to Oversized Size
Qualitest Pharmaceuticals is recalling 897,379 bottles of Hydrocodone bitartrate and acetaminophen tablets because a complaint reported the tablets were oversized.
Product
Hydrocodone bitartrate and acetaminophen Tablets, USP, 10 mg/500 mg, packaged in a) 30-count bottles, NDC 0603-3888-16; b) 60-count bottles, NDC 0603-3888-20; c) 90-count bottles, NDC 0603-3888-02; d) 100-count bottles, NDC 0603-3888-21; e) 120-count bottles, NDC 0603-3888-22; f)
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-108-2013·2013-01-09
FDA Recalls Methylprednisolone Acetate Injection Due to Non-Sterility
New England Compounding Center is recalling 23,897 vials of Methylprednisolone Acetate Injection nationwide due to non-sterility concerns.
Product
Methylprednisolone Acetate (PF) 80 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-109-2013·2013-01-09
FDA Recalls Methylprednisolone Acetate Injection Due to Non-Sterility
New England Compounding Center is recalling 9,062 vials of Methylprednisolone Acetate Injection because they may not be sterile. The recall is nationwide.
Product
Methylprednisolone Acetate (PF) 40 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-110-2013·2013-01-09
FDA Recalls Methylprednisolone Acetate Injection Due to Non-Sterility
New England Compounding Center is recalling 5,130 vials of Methylprednisolone Acetate Injection nationwide due to non-sterility concerns.
Product
Methylprednisolone Acetate 40 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-111-2013·2013-01-09
FDA Recalls Methylprednisolone Acetate Injection Due to Non-Sterility
New England Compounding Center is recalling 3,822 vials of Methylprednisolone Acetate 80 mg/mL Injection nationwide due to non-sterility concerns.
Product
Methylprednisolone Acetate 80 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-038-2013·2012-11-07
FDA Recalls Unapproved X-Rock 3 Day Pill For Men
Coral Rock Man, Inc. is recalling X-Rock 3 Day Pill For Men because the product was marketed without an approved NDA/ANDA and tested positive for Sildenafil and analogs.
Product
X-ROCK 3 Day Pill For Men, supplied in 1 and 2 capsule blister packs and 6, 12 and 24 count bottles, UPC 0 00309 50792 7, Distributed by: MATE Enterprises, Miami, Florida 33139, Some labeled as: Manufactured by CRM Laboratories, Distributed by XRock Industries, Ft. Lauderdale, F
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-039-2013·2012-11-07
Z-ROCK Male Supplement Recalled for Unapproved Sildenafil Content
Coral Rock Man, Inc. is recalling Z-ROCK All Natural Male Supplement because testing revealed the presence of Sildenafil and its analogs, which were not approved in the product.
Product
Z-ROCK All Natural Male Supplement. 1 capsule blister pack, UPC 0 00309 50792 7, Distributed by Zrock USA PO Box 668297, Pompano Beach, FL 33066
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-037-2013·2012-11-07
X-ROCK For Men Recalled for Unapproved Prescription Drug Ingredients
XRock Industries is recalling X-ROCK For Men dietary supplements because testing revealed the presence of unapproved prescription drug ingredients.
Product
X-ROCK For Men, Dietary Supplement, Manufactured by CRM Laboratories, Distributed by XRock Industries, PO Box 120863, Ft. Lauderdale, FL 33312, 0 00309 50792 7. UPC on labeling is: 0 00309 50792 7. UPC in Press Release is: 0030950792.
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-020-2013·2012-10-31
Hospira Recalls Overfilled Hydromorphone Hydrochloride Injection Cartridges
Hospira is recalling 216,880 units of Hydromorphone Hydrochloride Injection because the prefilled cartridges were found to be overfilled, containing more than the labeled 1 mL volume.
Product
HYDROMORPHONE HYDROCHLORIDE — HYDROMORPHONE HYDROCHLORIDE (HYDROMORPHONE HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1700-2012·2012-10-03
Japan Weight Loss Blue Capsules Recalled for Unapproved Sibutramine
Vitaminbestbuy.com is recalling Japan Weight Loss Blue Capsules because they contain sibutramine, an unapproved drug ingredient.
Product
Japan Weight Loss Blue Capsules, 9 g (300 mg), 30 count box, Green algae lipotropic (fat dissolving) agent, OTC, Distributed by Vitaminbestbuy.com, Brewerton, NY
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1698-2012·2012-10-03
FDA Recalls Hard Ten Days Capsules for Unapproved Sildenafil
The FDA is recalling Hard Ten Days Capsules because they contain sildenafil, an unapproved active ingredient. Consumers should stop using the product.
Product
Hard Ten Days Capsule, 4500 mg, boxes of 6 packets, OTC, Developed by: American Federal International Living Creature Group and Tibet Gold Source Living Creature Engineering Limited Company, Unit 18, 55 Beijing Road Central, Lhasa, Tibet
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1657-2012·2012-08-29
FDA Recalls V Maxx Rx Male Enhancement Product for Unapproved Drug Content
The Menz Club, LLC is recalling V Maxx Rx because FDA testing found it contains an unapproved drug analogue.
Product
V Maxx Rx, All Natural Male Enhancement, a) 1-count blister pack UPC Code 2802803561; b) 5-count blister pack UPC Code 0972859402; c) 10-count bottle UPC code 0913251017 bottles, Manufactured by The Menz Club, LLC, 103 W. Washington Street, Suite B5, Ridgeland, MS 39157, Phone:
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1444-2012·2012-08-15
Hospira Recalls Overfilled Hydromorphone Hydrochloride Prefilled Cartridges
Hospira Inc. is recalling 223,750 units of Hydromorphone Hydrochloride Injection because some prefilled cartridges contain more than the labeled 1 mL volume.
Product
HYDROMORPHONE HYDROCHLORIDE — HYDROMORPHONE HYDROCHLORIDE (HYDROMORPHONE HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1419-2012·2012-07-25
Hospira Recalls Morphine Sulfate Injection Cartridges Due to Overfilling
Hospira Inc. is recalling Morphine Sulfate Injection cartridges that contain 2.2 mL instead of the labeled 1 mL, posing a risk of overdose.
Product
Morphine Sulfate Injection, USP, 4mg/mL, 1 mL fill in 2.5 mL Carpuject Cartridge Unit with Luer Lock, packaged 10 Carpujects/carton, CII, Rx only, Hospira, Inc., Lake Forest, IL ---- NDC 0409-1258-30
Category
Drug
Distribution
Distributed nationwide
CriticalFDA (Drugs)·D-1386-2012·2012-06-27
Physicians Total Care Recalls Morphine Sulfate Tablets Due to Labeling Error
Physicians Total Care is recalling Morphine Sulfate tablets because bottles may be mislabeled, potentially containing the wrong formulation.
Product
Morphine Sulfate Immediate Release tablet, 30 mg/120 tablet bottles, Rx only, Physician Total Care, Inc, Tulsa, OK 74146-6234, NDC 54868-4973-00
Category
Drug
Distribution
1 state

How to read this listing

Filters

826–840 of 840